REVERSING IMMUNOTHERAPY RESISTANCE IN OVARIAN CANCER BY TARGETING A NOVEL IMMUNE-SUPPRESSIVE FACTOR RELEASED BY TUMOR-ASSOCIATED MACROPHAGES (TAMS)
$388,999FY2017Department of the ArmyDOD
Mainehealth, Portland ME
Investigators
View source on USAspending →REVERSING IMMUNOTHERAPY RESISTANCE IN OVARIAN CANCER BY TARGETING A NOVEL IMMUNE-SUPPRESSIVE FACTOR RELEASED BY TUMOR-ASSOCIATED MACROPHAGES (TAMS) · GrantIndex